A commentary on ‘Plasma metabolomics study in screening and differential diagnosis of multiple primary lung cancer’

aDepartment of Thoracic Oncology, Hefei Cancer Hospital, Chinese Academy of Sciences, Hefei 230000, China bSchool of Chemistry and Pharmaceutical Engineering, Hefei Normal University, Hefei 230601, China cDepartment of Medical Oncology, 901 Hospital of Joint Logistics Support Force of People Liberation Army, Hefei 230031, China This is a commentary (internal reviewed) Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article. Published online ■ ■ *Corresponding author. Address: CHINA. E-mail address: [email protected] (D. Lv). This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0/